Provider

They plan to infuse AI, big data, and cloud technologies with digital therapeutics.

A postponed launch and technical hurdles have hampered the testing phase of digital prescriptions in Germany, and the country now enters a prolonged piloting phase at the start of 2022.

The company merge will further innovate digital healthcare in the UK.

According to a study published in JMIR, providers are generally positive about remote therapy and tele-rehabilitation, but they need more training and support to overcome obstacles like technology hurdles and practical concerns.

Researchers did not find a significant reduction in the rate of hospitalizations between participants in the standard care group and those in the digital intervention group. 

As another pandemic year ends, leaders in the digital health space reflect on what the industry has learned in 2021.

Experts share their predictions for the year ahead.

It's a seismic acquisition, one that was first floated more than 13 years ago. Now that it's finally happening (pending regulatory approval), observers assess the deal and offer thoughts on what's next.

"There’s no need to wait until October 6. Anyone ready to share more than the USCDI v1 is welcome and encouraged to do so as permitted under applicable law."

Also, Iktos and the University of Dundee partner to design drugs for tropical diseases.